Craig Hallum downgraded shares of Axcelis Technologies (NASDAQ:ACLS – Free Report) from a buy rating to a hold rating in a research note released on Friday morning, MarketBeat reports. The firm currently has $140.00 price objective on the semiconductor company’s stock. ACLS has been the subject of several other reports. Bank of America lifted their […]
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | Akamai Technologies (NASDAQ:AKAM) Price Target Raised to $140.00 | 0 | 11.84 | 10-08-2026 |
| 2 | Royal Bank Of Canada Cuts Akamai Technologies (NASDAQ:AKAM) Price Target to $135.00 | 0 | 10.17 | 10-08-2026 |
| 3 | Akebia Therapeutics (NASDAQ:AKBA) Cut to Market Perform at Leerink Partners | 0 | 9.79 | 10-08-2026 |
| 4 | Akamai Technologies (NASDAQ:AKAM) Price Target Raised to $190.00 | 0 | 12.21 | 10-08-2026 |
| 5 | Wall Street Zen Downgrades Optical Cable (NASDAQ:OCC) to Hold | 0 | 6.67 | 27-07-2026 |
| 6 | Applied Optoelectronics’ (AAOI) Buy Rating Reiterated at Rosenblatt Securities | 0 | 10.32 | 10-08-2026 |
| 7 | Microchip Technology’s (MCHP) Buy Rating Reiterated at Rosenblatt Securities | 0 | 7.99 | 10-08-2026 |
| 8 | SpaceX (NASDAQ:SPCX) Upgraded at Argus | 0 | 8.75 | 10-08-2026 |
| 9 | Celldex Therapeutics (NASDAQ:CLDX) Price Target Raised to $53.00 | 0 | 11.84 | 10-08-2026 |